Font: Financial Modeling Prep • Aug 02, 2026
Parsons Corporation (NYSE: PSN) is a leading technology solutions provider serving the defense sector, intelligence community, and critical infrastructure markets. The company’s stock has been highly volatile over the past year, trading between $36.26 and $89.50. Its market capitalization is approximately $4.72 billion.
On August 3, 2026, Jefferies upgraded Parsons Corporation to a “Buy” rating from “Hold.” However, the firm reduced its price target to $52.00 from $60.00. The new target implies potential upside of approximately 17.6% from the stock’s recent price of $44.21.
Parsons’ second-quarter 2026 results were affected by significant charges and portfolio-shaping actions. The company reported revenue of approximately $1.6 billion, down 1% year over year. Adjusted diluted EPS was ($0.06), compared with the analyst consensus estimate of $0.76. The company’s GAAP diluted EPS was ($0.14).
The EPS shortfall was primarily linked to $118 million in charges related to portfolio actions and a joint venture program. Excluding these charges, adjusted EBITDA increased 8% year over year to $161 million, indicating that the company’s underlying operations remained relatively resilient.
On July 29, 2026, Parsons reduced its full-year revenue guidance to between $6.2 billion and $6.5 billion, compared with its previous range of $6.5 billion to $6.8 billion. The company also lowered its adjusted EBITDA guidance to between $500 million and $560 million from $615 million to $675 million.
The guidance reduction triggered a sharp decline in Parsons Corporation’s stock price. Shares traded as low as $39.50 following the earnings announcement, marking a new 52-week low at that time.
Despite the weak earnings and lower guidance, Parsons reported several positive indicators. Contract awards rose 24% year over year, and the book-to-bill ratio reached 1.2x. This suggests that the company is securing new orders faster than it is completing existing work, signaling continued demand for its defense, infrastructure, and technology services.
|
ADGM§>
Adagio Medical Holdings, Inc.
|
$0.80
73.91%
|
|
TNMG§>
TNL Mediagene
|
$0.48
33.06%
|
|
ENSC§>
Ensysce Biosciences, Inc.
|
$0.38
37.17%
|
|
PLTR§>
Palantir Technologies Inc.
|
$162.66
29.45%
|
|
SXTC§>
China SXT Pharmaceuticals, Inc.
|
$0.12
60.08%
|
|
NVDA§>
NVIDIA Corporation
|
$211.94
2.56%
|
|
QNME§>
Lakeside Holding Limited
|
$0.69
-37.59%
|
|
AMIX§>
Autonomix Medical, Inc.
|
$19.50
434.25%
|
|
INTC§>
Intel Corp.
|
$100.86
10.84%
|
|
VTGN§>
VistaGen Therapeutics, Inc.
|
$0.30
22.45%
|